within Pharmacolibrary.Drugs.ATC.G;

model G01AF01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.99,
    Cl             = 1.633333333333333e-05,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00055,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0085,
    Tlag           = 10.200000000000001
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G01AF01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Metronidazole is a nitroimidazole antibiotic and antiprotozoal medication used for the treatment of infections caused by anaerobic bacteria and certain parasites, including bacterial vaginosis, trichomoniasis, and giardiasis. It is widely approved and used globally in clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers following single oral administration.</p><h4>References</h4><ol><li><p>Lamp, KC, et al., &amp; Lacy, MK (1999). Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials. <i>Clinical pharmacokinetics</i> 36(5) 353–373. DOI:<a href=\"https://doi.org/10.2165/00003088-199936050-00004\">10.2165/00003088-199936050-00004</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/10384859/\">https://pubmed.ncbi.nlm.nih.gov/10384859</a></p></li><li><p>Louie, TJ, et al., &amp; Shue, YK (2011). Fidaxomicin versus vancomycin for Clostridium difficile infection. <i>The New England journal of medicine</i> 364(5) 422–431. DOI:<a href=\"https://doi.org/10.1056/NEJMoa0910812\">10.1056/NEJMoa0910812</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21288078/\">https://pubmed.ncbi.nlm.nih.gov/21288078</a></p></li><li><p>Mimura, Y, et al., &amp; Kuragano, T (2020). The pharmacokinetics of oral metronidazole in patients with metronidazole-induced encephalopathy undergoing maintenance hemodialysis. <i>Hemodialysis international. International Symposium on Home Hemodialysis</i> 24(4) 528–533. DOI:<a href=\"https://doi.org/10.1111/hdi.12857\">10.1111/hdi.12857</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33460224/\">https://pubmed.ncbi.nlm.nih.gov/33460224</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G01AF01;
